News and Announcements
Universal Biosensors Q3 2015 Results, Investor Presentation and CEO Audio Interview
- Published October 30, 2015 12:16PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
29th October 2015, ASX Announcement
- Total revenue up 187% on pcp to $6.0m
- Quarterly Service Fees up 113% on pcp to $3.4m
- Coagulation strip manufacturing revenue up 303% on pcp to $553k
- Net R&D costs (including accrued R&D tax rebate) of $2.6m
- Net loss of 163k (down from $1.9m on pcp)
- Cash balance as at 30 September 2015 of $17.4m
To read the full announcement, please click here.
To view the Investor Presentation, please click here.
To listen to the CEO Interview, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
